Dear Matt, we have found in a study about PBL lymphocyte subpopulation in ENT-carcinoma patients (controlls, acutely get sick patients, cured patients, patients with recurrence, together nearly 250 probands) a mean presence of CD4+8+ lymphocytes between 4 and 7 %. Further there was in parts a parallelism between CD4+8+ and the presence of CD3+HLA-DR+ or CD3+CD56+ lymphocytes. May be this is helpfull Greetings Dr.J.Ostwald ENT-Clinic University Rostock Germany
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:58:00 EST